Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells (Q80229494)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Yan Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Qun Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yan Hang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Xuexian Bu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

William Jia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

2374-2382

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

Estrogen and the risk of breast cancer

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Sex hormones in women in rural China and in Britain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Adjuvant tamoxifen and second cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Clinical pharmacology of selective estrogen receptor modulators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Tamoxifen-stimulated growth of human endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

High-grade endometrial stromal sarcoma after treatment with tamoxifen in a patient treated for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

In vitro induction of differentiation by ginsenoides in F9 teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Involvement of glucocorticoid receptor in the induction of differentiation by ginsenosides in F9 teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

A ginsenoside-Rh1, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Mycotoxins in root extracts of American and Asian ginseng bind estrogen receptors alpha and beta.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

American ginseng transcriptionally activates p21 mRNA in breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Metabolism of 20(S)- and 20(R)-Ginsenoside Rg3 by Human Intestinal Bacteria and Its Relation to in Vitro Biological Activities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Degradation of ginsenosides in humans after oral administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Structural insights into the mechanisms of agonism and antagonism in oestrogen receptor isoforms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Combined antitumor activity of 7-hydroxystaurosporine (UCN-01) and tamoxifen against human breast carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22659

7 January 2021

Identifiers

DOI

10.1002/CNCR.22659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464948%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference